Independent register of U.S. FDA drug recalls · updated Oct 14, 2026
RxRecalls Get alerts

FDA Drug Recalls

11,818 recalls · Class II, newest first

Class II · Moderate risk

Rugby Aller-chlor

Microbial contamination of Non-sterile Products; presence of yeast and potential B. cepacia contamination

Terminated Microbial contamination The Harvard Drug Group D-1122-2017
Class II · Moderate risk

Rugby Diocto Syrup

Microbial contamination of Non-sterile Products; presence of yeast and potential B. cepacia contamination

Terminated Microbial contamination The Harvard Drug Group D-1120-2017
Class II · Moderate risk

Rugby Diocto Liquid

Microbial contamination of Non-sterile Products; presence of yeast and potential B. cepacia contamination

Terminated Microbial contamination The Harvard Drug Group D-1119-2017
Class II · Moderate risk

Famotidine USP 20 mg

Failed Tablet/Capsule Specification: out of specification for tablet weight.

Terminated Failed specification PD-Rx Pharmaceuticals, Inc. NDC 55289-765-30 D-1057-2017
Class II · Moderate risk

Famotidine Tablets USP

Failed Tablet/Capsule Specification; out of specification for tablet weight

Terminated Failed specification Teva Pharmaceuticals USA NDC 0172-5728-60 D-1056-2017
Class II · Moderate risk

Entecavir Tablets 0.5 mg

Failed Impurities/Degradation Specification: single unknown impurity OOS 0.33% (Limit:NMT 0.20%W/W) at the three month stability point.

Terminated Impurity / degradation Hetero USA Inc NDC 31722-833-30 D-1095-2017
Class II · Moderate risk

Magnesium Citrate Oral Solution

Microbial contamination of non-sterile products: product was found to contain mold, identified as Rhinocladiella similis.

Terminated Microbial contamination Vi-Jon, Inc. NDC 50804-686-38 D-1054-2017

Recalls by year